Group One Trading’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-57,900
Closed -$166K 7101
2023
Q4
$166K Hold
57,900
﹤0.01% 4031
2023
Q3
$150K Hold
57,900
﹤0.01% 4065
2023
Q2
$232K Buy
+57,900
New +$253K ﹤0.01% 3782
2023
Q1
Sell
-4,343
Closed -$30.4K 7247
2022
Q4
$30.4K Hold
4,343
﹤0.01% 5332
2022
Q3
$57K Hold
4,343
﹤0.01% 5286
2022
Q2
$66K Sell
4,343
-1,300
-23% -$17.7K ﹤0.01% 5326
2022
Q1
$97K Sell
5,643
-1,900
-25% -$36.2K ﹤0.01% 5513
2021
Q4
$193K Buy
7,543
+6,093
+420% +$237K ﹤0.01% 5118
2021
Q3
$67K Buy
1,450
+700
+93% +$39.4K ﹤0.01% 6296
2021
Q2
$57K Buy
+750
New +$49.2K ﹤0.01% 6455

Other funds holding CALC

Group One Trading's CALC Position: Q2 2022 in Review

Group One Trading sold out of CalciMedica (CALC) in Q2 2022, closing a stake of 176 shares — an estimated $2.4K sold.

Group One Trading first reported a position in CALC in Q2 2021 and held it in 3 quarters. The position peaked at $86K in Q2 2021. 25 funds tracked by Wall St. Rank hold CALC as of Q2 2022.

  • Group One Trading reported no remaining CalciMedica position as of Q2 2022 after selling out during the quarter.
  • Group One Trading sold 176 CalciMedica shares in Q2 2022, an estimated $2.4K.
  • Group One Trading first reported a position in CalciMedica in Q2 2021 and held it in 3 quarters.
  • Group One Trading's CalciMedica position peaked at $86K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held CalciMedica as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.